Sažetak
Uvod/Cilj. Sindrom opstruktivne apneje-hipopneje u snu (obstructive sleep apnea-hypopnea syndrome – OSAHS) povezan je sa povećanim kardiovaskularnim rizikom (KVR). Cilj rada bio je da se ispita KVR kod obolelih od hipertenzije i OSAHS korišćenjem skorova rizika Systematic Coronary Risk Evaluation 2 (SCORE2), SCORE2-Dijabetes i American College of Cardiology/American Heart Association for atherosclerotic cardiovascular disease (ACC/AHA ASCVD). Metode. Zbog strogih krterijuma isključenja od 410 uzastopnih bolesnika obolelih od OSAHS, 92 hipertenzivna bolesnika sa umerenim ili teškim OSAHS uključena su u studiju. Svi ispitanici podvrgnuti su proceni KVR-a korišćenjem SCORE2, SCORE2-Dijabetes i ACC/AHA ASCVD skorova rizika. Takođe, svi bolesnici, osim sedmoro sa ekstremnom gojaznošću (težina preko 130 kg) koji nisu mogli da urade test, podvrgnuti su testu fizičkim opterećenjem, a šestoro njih zahtevalo je dalju dijagnostičku procenu korišćenjem stres ehokardiografije (troje), kompjuterizovane tomografije koronarnih arterija (dvoje) i/ili invazivne koronarne angiografije (troje). Rezultati. Rezultati su pokazali značajno opterećenje umerenim do visokim KVR-om prema svim skorovima. Teški oblik OSAHS bio je povezan sa višim procentom umerenog do visokog KVR-a, posebno prema ACC/AHA ASCVD kalkulatoru. Nije pokazana značajna korelacija između indeksa apneje-hipopneje i KVR-a. Takođe, kod troje bolesnika, invazivna koronarna angiografija pokazala je višesudovnu koronarnu bolest koja je zahtevala revaskularizaciju miokarda. Zaključak. Opšti sistemi bodovanja KVR-a mogu neadekvatno prikazati specifični KVR kod obolelih od OSAHS, što naglašava potrebu za prilagođenom procenom rizika i pojačanim ranim otkrivanjem koronarne arterijske bolesti u ovoj populaciji. Naši rezultati naglašavaju klinički značaj detekcije koronarne arterijske bolest kod osoba sa OSAHS.
Ključne reči
Array
Array
Array
Array
Reference
Benjafield AV, Ayas NT, Eastwood PR, Heinzer R, Ip MSM, Morrell MJ, et al. Estimation of the global prevalence and bur-den of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med 2019; 7(8): 687–98.
Nguyen Hai C, Trinh Duc L. Sleep Disorders and Traffic Acci-dents: Unveiling the Hidden Risks. Am J Case Rep 2024; 25: e943346.
Osman AM, Carter SG, Carberry JC, Eckert DJ. Obstructive sleep apnea: current perspectives. Nat Sci Sleep 2018; 10: 21–34.
Kasai T, Floras JS, Bradley TD. Sleep apnea and cardiovascular disease: a bidirectional relationship. Circulation 2012; 126(12): 1495–510.
Blackwell JN, Walker M, Stafford P, Estrada S, Adabag S, Kwon Y. Sleep Apnea and Sudden Cardiac Death. Circ Rep 2019; 1(12): 568–74.
Graham IM, Di Angelantonio E, Huculeci R; European Society of Cardiology’s Cardiovascular Risk Collaboration (CRC). New Way to "SCORE" Risk: Updates on the ESC Scoring System and Incorporation into ESC Cardiovascular Prevention Guide-lines. Curr Cardiol Rep 2022; 24(11): 1679–84.
SCORE2-Diabetes Working Group and the ESC Cardiovascular Risk Collaboration. SCORE2-Diabetes: 10-year cardiovascular risk estimation in type 2 diabetes in Europe. Eur Heart J 2023; 44(28): 2544–56.
Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. 2019 ACC/AHA Guideline on the Prima-ry Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2019; 140(11): e596–95. Erratum in: Circulation 2019; 140(11): e647–8. Erratum in: Circulation 2020; 141(4): e59. Erratum in: Circulation 2020; 141(16): e773.
Mancia G, Kreutz R, Brunström M, Burnier M, Grassi G, Janusze-wicz A, et al. 2023 ESH Guidelines for the management of ar-terial hypertension The Task Force for the management of ar-terial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens 2023; 41(12): 1874–2071. Erratum in: J Hypertens 2024; 42(1): 194.
Kapur VK, Auckley DH, Chowdhuri S, Kuhlmann DC, Mehra R, Ramar K, et al. Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea: An American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med 2017; 13(3): 479–504.
Geer JH, Hilbert J. Gender Issues in Obstructive Sleep Apnea. Yale J Biol Med 2021; 94(3): 487–96.
Tom C, Roy B, Vig R, Kang DW, Aysola RS, Woo MA, et al. Correlations between Waist and Neck Circumferences and Obstructive Sleep Apnea Characteristics. Sleep Vigil 2018; 2(2): 111–8.
Mitra AK, Bhuiyan AR, Jones EA. Association and Risk Factors for Obstructive Sleep Apnea and Cardiovascular Diseases: A Systematic Review. Diseases 2021; 9(4): 88.
Kurnool S, McCowen KC, Bernstein NA, Malhotra A. Sleep Ap-nea, Obesity, and Diabetes - an Intertwined Trio. Curr Diab Rep 2023; 23(7): 165–71.
Archontogeorgis K, Voulgaris A, Nena E, Strempela M, Karailidou P, Tzouvelekis A, et al. Cardiovascular Risk Assessment in a Cohort of Newly Diagnosed Patients with Obstructive Sleep Apnea Syndrome. Cardiol Res Pract 2018; 2018: 6572785.
Borsini E, Blanco M, Bosio M, Schrappe M, Ernst G, Nosetto D, et al. Prevalence of sleep apnea and cardiovascular risk factors in patients with hypertension in a day hospital model. Clin Exp Hypertens 2018; 40(3): 231–7.
Wolk R, Shamsuzzaman AS, Somers VK. Obesity, sleep apnea, and hypertension. Hypertension 2003; 42(6): 1067–74.
Pennings N, Golden L, Yashi K, Tondt J, Bays HE. Sleep-disordered breathing, sleep apnea, and other obesity-related sleep disorders: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022. Obes Pillars 2022; 4: 100043.
Giampá SQC, Lorenzi-Filho G, Drager LF. Obstructive sleep apnea and metabolic syndrome. Obesity (Silver Spring) 2023; 31(4): 900–11.
Wang L, Ou Q, Shan G, Lao M, Pei G, Xu Y, et al. Independ-ent Association Between Oxygen Desaturation Index and Cardiovascular Disease in Non-Sleepy Sleep-Disordered Breathing Subtype: A Chinese Community-Based Study. Nat Sci Sleep 2022; 14: 1397–406.
Trzepizur W, Blanchard M, Ganem T, Balusson F, Feuilloy M, Gi-rault JM, et al. Sleep Apnea-Specific Hypoxic Burden, Symp-tom Subtypes, and Risk of Cardiovascular Events and All-Cause Mortality. Am J Respir Crit Care Med 2022; 205(1): 108–17.
Mehra R, Azarbarzin A. Sleep Apnea-Specific Hypoxic Burden and Not the Sleepy Phenotype as a Novel Measure of Cardio-vascular and Mortality Risk in a Clinical Cohort. Am J Respir Crit Care Med 2022; 205(1): 12–3.
Butner KL, Hargens TA, Kaleth AS, Miller LE, Zedalis D, Her-bert WG. Association of Obstructive Sleep Apnea Severity with Exercise Capacity and Health-related Quality of Life. N Am J Med Sci 2013; 5(6): 362–6.
Yeghiazarians Y, Jneid H, Tietjens JR, Redline S, Brown DL, El-Sherif N, et al. Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart As-sociation. Circulation 2021; 144(3): e56–67. Erratum in: Cir-culation 2022; 145(12): e775.
Lüthje L, Andreas S. Obstructive sleep apnea and coronary ar-tery disease. Sleep Med Rev 2008; 12(1): 19–31.